MX2009005445A - Sistema de suministro para risperidona. - Google Patents

Sistema de suministro para risperidona.

Info

Publication number
MX2009005445A
MX2009005445A MX2009005445A MX2009005445A MX2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A
Authority
MX
Mexico
Prior art keywords
risperidone
delivery system
polymer
formulation
skin
Prior art date
Application number
MX2009005445A
Other languages
English (en)
Spanish (es)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005445A publication Critical patent/MX2009005445A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009005445A 2006-11-22 2007-11-21 Sistema de suministro para risperidona. MX2009005445A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062628 WO2008062009A1 (en) 2006-11-22 2007-11-21 Delivery system for risperidone

Publications (1)

Publication Number Publication Date
MX2009005445A true MX2009005445A (es) 2009-06-02

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Country Status (6)

Country Link
US (2) US20100203104A1 (cg-RX-API-DMAC7.html)
EP (2) EP2094270A1 (cg-RX-API-DMAC7.html)
JP (2) JP2010510287A (cg-RX-API-DMAC7.html)
CA (2) CA2670454A1 (cg-RX-API-DMAC7.html)
MX (2) MX2009005445A (cg-RX-API-DMAC7.html)
WO (2) WO2008062009A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
RU2444364C2 (ru) * 2006-07-12 2012-03-10 Контроллд Терапьютикс (Скотлэнд) Лтд. Полимер для доставки лекарств с гидрохлоридной солью клиндамицина
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2094270A1 (en) * 2006-11-22 2009-09-02 N.V. Organon Delivery system for risperidone
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
US9078900B2 (en) * 2008-09-30 2015-07-14 Braeburn Pharmaceuticals Bvba Sprl Implantable device for the delivery of risperidone and methods of use thereof
WO2010105093A2 (en) * 2009-03-12 2010-09-16 Delpor, Inc. Implantable device for long-term delivery of drugs
MX354444B (es) 2010-03-16 2018-03-06 Titan Pharmaceuticals Inc Dispositivos implantables heterogeneos para suministro de medicamento.
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
MX2020012459A (es) * 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
EP4329734A4 (en) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Implantable device for the delayed release of a macromolecular drug compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
ES2166894T3 (es) * 1995-07-04 2002-05-01 Akzo Nobel Nv Dispositivos anulares.
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
WO2002076426A2 (en) * 2001-03-27 2002-10-03 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
IL166687A0 (en) * 2002-08-30 2006-01-15 Alza Corp Embossable and writable multilaminate backing construction
EP2633853A1 (en) * 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Long-term delivery formulations and methods of use thereof
MXPA06010905A (es) * 2004-03-24 2007-03-08 Organon Nv Sistema para el suministro de farmacos basados en copolimeros de polietileno y acetato de vinilo.
RS53890B1 (sr) * 2004-11-10 2015-08-31 Tolmar Therapeutics, Inc. Stabilizovan polimerni sistem za isporuku
EP2094270A1 (en) * 2006-11-22 2009-09-02 N.V. Organon Delivery system for risperidone
MX2009005446A (es) * 2006-11-22 2009-06-02 Organon Nv Sistema de suministro vaginal para mirtazapina.

Also Published As

Publication number Publication date
MX2009005444A (es) 2009-06-02
CA2670157A1 (en) 2008-05-29
WO2008062009A1 (en) 2008-05-29
US20100203104A1 (en) 2010-08-12
CA2670454A1 (en) 2008-05-29
JP2010510287A (ja) 2010-04-02
EP2094348A1 (en) 2009-09-02
EP2094270A1 (en) 2009-09-02
WO2008062008A1 (en) 2008-05-29
JP2010510286A (ja) 2010-04-02
US20100104619A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
MX2009005445A (es) Sistema de suministro para risperidona.
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
WO2008148478A3 (de) Gastroretentives system mit alginat-körper
CA2770353C (en) Insertion device systems and methods
MX2009005446A (es) Sistema de suministro vaginal para mirtazapina.
WO2008101486A3 (de) Beschichtetes expandierbares system
WO2013085901A3 (en) Systems and methods for delivery of a medical device
WO2010035273A3 (en) Novel gastroretentive delivery system
WO2008063341A3 (en) Dual action, inhaled formulations providing both an immediate and sustained release profile
CL2008003421A1 (es) Sistema de administracion intravaginal con un compartimiento que comprende drospirenona y un compartimiento, igual o diferente, con un estrogeno, cada compartimiento comprende un nucleo y una membrana que lo recubre que consisten de una composicion de polimero que contiene un elastomero basado en polidimetilsiloxano con grupos polioxido de alquileno.
WO2006084164A8 (en) Gastric retention and controlled release delivery system
WO2010105995A3 (en) Zoo-technical drug delivery device
WO2010019597A3 (en) Cyclo olefin polymer and copolymer medical devices
WO2010062589A3 (en) Device for delivery of antimicrobial agent into trans-dermal catheter
WO2007126531A3 (en) Methods and devices for deployment into a lumen
WO2008078318A3 (en) Systems and devices for sustained delivery of therapeutic fluid
EP1998751A4 (en) Devices, systems and methods for medicament delivery
WO2008002434A3 (en) Medical devices for release of low solubility therapeutic agents
WO2012042474A8 (en) Stoma length indicator assembly and positioning system
WO2012017063A3 (en) Method and system for retaining a cartridge in a holder
WO2013009998A3 (en) Device for delivery of antimicrobial agent into trans-dermal catheter
WO2009105432A3 (en) Devices and methods for delivery of a therapeutic agent through a pneumostoma
WO2007130663A3 (en) Method, device, and system for delivery of therapeutic agents to the eye
WO2009032737A3 (en) Systems and methods for delivering medication

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal